Why was levobunolol discontinued? Understanding the Market and Therapeutic Evolution
•
3 min read
While the active ingredient is still available in some forms, specific formulations of levobunolol, such as the 0.25% strength and preservative-free unit-doses, have been discontinued. The decision to withdraw these particular products from the market is a complex story involving business factors, market dynamics, and the evolution of glaucoma treatment.
